Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Clean Power Hydrogen reports solid full-year progress

(Sharecast News) - UK-based green hydrogen technology company Clean Power Hydrogen (CPH2) reported solid progress towards the commercial rollout of its membrane-free electrolyser (MFE) technology in its final results on Friday, driven by a revamped engineering team. The AIM-traded firm successfully operated the entire MFE110 system at scale during the year, along with functional testing of the control programme enabling automatic operation and shutdown.

Improvements were also made to key components, while rigorous testing informed valuable enhancements for the MFE220 design.

Financially, CPH2 reported a year-end net asset position of £21m, with £8.5m in cash or current asset investments.

The company invested £2.8m in research and design during the 12-month period.

CPH2 said it had also entered into a 10-year licensing agreement with Fabrum Solutions, granting non-exclusive rights to manufacture and sell membrane-free electrolysers in New Zealand and Australia.

The company said it was also engaged in advanced discussions with multiple potential partners for new licences and orders.

In terms of certifications, CPH2 was awarded three ISO certifications, including ISO 45001 for occupational health and safety, ISO 14001 for environmental management systems, and ISO 9001 for quality management systems.

Looking ahead, the company said it expected to complete factory acceptance testing for the MFE110 within the next three months.

Additionally, the completion and delivery of the MFE220, a 1MW system for Northern Ireland Water, was expected within the next 12 months.

"2023 has been a year of further progress for CPH2, both operationally and technically," said chief executive officer Jon Duffy.

"Our focus has centred on developing our unique technology for commercialisation, ensuring safety and scalability through rigorous testing of the MFE110.

"The successful running of the entire MFE110 system, producing separated hydrogen and oxygen gases, stands as a key milestone for CPH2, proving our differentiated technology works at scale."

At 0803 BST, shares in Clean Power Hydrogen were up 2.58% at 15.9p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

CVS Health shares fall on earnings miss, lowered outlook
(Sharecast News) - Shares in pharmacy giant CVS Health were falling on Wednesday, after its first-quarter results fell short of expectations, with both revenue and adjusted earnings missing the mark.
Ariana sets out fresh production guidance for Zenit
(Sharecast News) - Mineral explorer and developer Ariana Resources announced its production guidance for 2024 from its stake in the Zenit mining operations on Wednesday.
Johnson & Johnson proposes $6.5bn deal to settle talc claims
(Sharecast News) - Johnson & Johnson has proposed a $6.5bn deal to settle thousands of lawsuits claiming its talc products cause cancer, it was confirmed on Wednesday.
Safestay acquires Cordoba hotel for EUR 2m
(Sharecast News) - Safestay announced the acquisition of Hotel Lineros in Cordoba, Spain on Wednesday, for €2m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.